Assessment of exhaled breath condensate for non-invasive diagnosis of gastroesophageal reflux disease

M. Doubková (Krenovice, Czech Republic)

Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Session: Chronic airway disease: markers of disease impact
Session type: Thematic Poster
Number: 4008

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Doubková (Krenovice, Czech Republic). Assessment of exhaled breath condensate for non-invasive diagnosis of gastroesophageal reflux disease. 4008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Iron concentrations in exhaled breath condensate of children with asthma and gastroesophageal reflux disease
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Identification of laryngopharyngeal reflux and acid aspiration using exhaled breath condensate pH
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005


Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease?
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009

Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005



Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


Rapid pH-measurement in exhaled breath condensate with an innovative pH-IsFET
Source: Eur Respir J 2006; 28: Suppl. 50, 789s
Year: 2006

Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Exhaled breath CO and induced sputum in noninvasive assessment of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003

Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018